Scpharmaceuticals 

$5.67
13
+$0+0% Monday 20:00

Statistics

Day High
5.67
Day Low
5.67
52W High
6.28
52W Low
1.94
Volume
9,239,268
Avg. Volume
1,442,407
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

5NovExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.75
-0.58
-0.41
-0.24
Expected EPS
-0.243333
Actual EPS
N/A

Financials

-234.36%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
36.33MRevenue
-85.15MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCPH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen develops similar biopharmaceutical products targeting serious illnesses, directly competing in some of scPharmaceuticals' markets.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the same biopharmaceutical space, offering products that could rival scPharmaceuticals' treatments in terms of therapeutic applications.
Pfizer
PFE
Mkt Cap140.15B
Pfizer has a broad portfolio of drugs that can compete with scPharmaceuticals' offerings, especially in the cardiovascular and infectious disease areas.
Merck
MRK
Mkt Cap214.76B
Merck produces a wide range of pharmaceuticals that could compete with scPharmaceuticals' products, particularly in the areas of infectious diseases and cardiology.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, develops medications that could directly compete with scPharmaceuticals' pipeline and marketed products.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences focuses on areas like infectious diseases, a key area for scPharmaceuticals, making them direct competitors in this space.
Novartis
NVS
Mkt Cap237.61B
Novartis offers a wide range of pharmaceutical products that compete with scPharmaceuticals, especially in the cardiovascular and oncology sectors.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb has a diverse portfolio in areas like cardiovascular, oncology, and immunoscience, overlapping with scPharmaceuticals' interests.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates in similar therapeutic areas as scPharmaceuticals, including cardiovascular and infectious diseases, making them direct competitors.
Sanofi
SNY
Mkt Cap124.45B
Sanofi focuses on a broad spectrum of healthcare solutions, including areas where scPharmaceuticals is active, thus posing competition in those markets.

About

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
Show more...
CEO
Mr. John H. Tucker
Employees
162
Country
US
ISIN
US8106481059

Listings

0 Comments

Share your thoughts

FAQ

What is Scpharmaceuticals stock price today?
The current price of SCPH is $5.67 USD — it has increased by +0% in the past 24 hours. Watch Scpharmaceuticals stock price performance more closely on the chart.
What is Scpharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scpharmaceuticals stocks are traded under the ticker SCPH.
Is Scpharmaceuticals stock price growing?
SCPH stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Scpharmaceuticals has showed a +143.35% increase.
What is Scpharmaceuticals revenue for the last year?
Scpharmaceuticals revenue for the last year amounts to 36.33M USD.
What is Scpharmaceuticals net income for the last year?
SCPH net income for the last year is -85.15M USD.
How many employees does Scpharmaceuticals have?
As of April 01, 2026, the company has 162 employees.
In which sector is Scpharmaceuticals located?
Scpharmaceuticals operates in the Health Care sector.
When did Scpharmaceuticals complete a stock split?
Scpharmaceuticals has not had any recent stock splits.
Where is Scpharmaceuticals headquartered?
Scpharmaceuticals is headquartered in Burlington, US.